Cargando…

Antimalarial drug use in general populations of tropical Africa

BACKGROUND: The burden of Plasmodium falciparum malaria has worsened because of the emergence of chloroquine resistance. Antimalarial drug use and drug pressure are critical factors contributing to the selection and spread of resistance. The present study explores the geographical, socio-economic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardella, Florence, Assi, Serge, Simon, Fabrice, Bogreau, Hervé, Eggelte, Teunis, Ba, Fatou, Foumane, Vincent, Henry, Marie-Claire, Kientega, Pélagie Traore, Basco, Léonardo, Trape, Jean-François, Lalou, Richard, Martelloni, Maryse, Desbordes, Marc, Baragatti, Meïli, Briolant, Sébastien, Almeras, Lionel, Pradines, Bruno, Fusai, Thierry, Rogier, Christophe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494551/
https://www.ncbi.nlm.nih.gov/pubmed/18611279
http://dx.doi.org/10.1186/1475-2875-7-124
_version_ 1782158224342908928
author Gardella, Florence
Assi, Serge
Simon, Fabrice
Bogreau, Hervé
Eggelte, Teunis
Ba, Fatou
Foumane, Vincent
Henry, Marie-Claire
Kientega, Pélagie Traore
Basco, Léonardo
Trape, Jean-François
Lalou, Richard
Martelloni, Maryse
Desbordes, Marc
Baragatti, Meïli
Briolant, Sébastien
Almeras, Lionel
Pradines, Bruno
Fusai, Thierry
Rogier, Christophe
author_facet Gardella, Florence
Assi, Serge
Simon, Fabrice
Bogreau, Hervé
Eggelte, Teunis
Ba, Fatou
Foumane, Vincent
Henry, Marie-Claire
Kientega, Pélagie Traore
Basco, Léonardo
Trape, Jean-François
Lalou, Richard
Martelloni, Maryse
Desbordes, Marc
Baragatti, Meïli
Briolant, Sébastien
Almeras, Lionel
Pradines, Bruno
Fusai, Thierry
Rogier, Christophe
author_sort Gardella, Florence
collection PubMed
description BACKGROUND: The burden of Plasmodium falciparum malaria has worsened because of the emergence of chloroquine resistance. Antimalarial drug use and drug pressure are critical factors contributing to the selection and spread of resistance. The present study explores the geographical, socio-economic and behavioural factors associated with the use of antimalarial drugs in Africa. METHODS: The presence of chloroquine (CQ), pyrimethamine (PYR) and other antimalarial drugs has been evaluated by immuno-capture and high-performance liquid chromatography in the urine samples of 3,052 children (2–9 y), randomly drawn in 2003 from the general populations at 30 sites in Senegal (10), Burkina-Faso (10) and Cameroon (10). Questionnaires have been administered to the parents of sampled children and to a random sample of households in each site. The presence of CQ in urine was analysed as dependent variable according to individual and site characteristics using a random – effect logistic regression model to take into account the interdependency of observations made within the same site. RESULTS: According to the sites, the prevalence rates of CQ and PYR ranged from 9% to 91% and from 0% to 21%, respectively. In multivariate analysis, the presence of CQ in urine was significantly associated with a history of fever during the three days preceding urine sampling (OR = 1.22, p = 0.043), socio-economic level of the population of the sites (OR = 2.74, p = 0.029), age (2–5 y = reference level; 6–9 y OR = 0.76, p = 0.002), prevalence of anti-circumsporozoite protein (CSP) antibodies (low prevalence: reference level; intermediate level OR = 2.47, p = 0.023), proportion of inhabitants who lived in another site one year before (OR = 2.53, p = 0.003), and duration to reach the nearest tarmacked road (duration less than one hour = reference level, duration equal to or more than one hour OR = 0.49, p = 0.019). CONCLUSION: Antimalarial drug pressure varied considerably from one site to another. It was significantly higher in areas with intermediate malaria transmission level and in the most accessible sites. Thus, P. falciparum strains arriving in cross-road sites or in areas with intermediate malaria transmission are exposed to higher drug pressure, which could favour the selection and the spread of drug resistance.
format Text
id pubmed-2494551
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24945512008-08-02 Antimalarial drug use in general populations of tropical Africa Gardella, Florence Assi, Serge Simon, Fabrice Bogreau, Hervé Eggelte, Teunis Ba, Fatou Foumane, Vincent Henry, Marie-Claire Kientega, Pélagie Traore Basco, Léonardo Trape, Jean-François Lalou, Richard Martelloni, Maryse Desbordes, Marc Baragatti, Meïli Briolant, Sébastien Almeras, Lionel Pradines, Bruno Fusai, Thierry Rogier, Christophe Malar J Research BACKGROUND: The burden of Plasmodium falciparum malaria has worsened because of the emergence of chloroquine resistance. Antimalarial drug use and drug pressure are critical factors contributing to the selection and spread of resistance. The present study explores the geographical, socio-economic and behavioural factors associated with the use of antimalarial drugs in Africa. METHODS: The presence of chloroquine (CQ), pyrimethamine (PYR) and other antimalarial drugs has been evaluated by immuno-capture and high-performance liquid chromatography in the urine samples of 3,052 children (2–9 y), randomly drawn in 2003 from the general populations at 30 sites in Senegal (10), Burkina-Faso (10) and Cameroon (10). Questionnaires have been administered to the parents of sampled children and to a random sample of households in each site. The presence of CQ in urine was analysed as dependent variable according to individual and site characteristics using a random – effect logistic regression model to take into account the interdependency of observations made within the same site. RESULTS: According to the sites, the prevalence rates of CQ and PYR ranged from 9% to 91% and from 0% to 21%, respectively. In multivariate analysis, the presence of CQ in urine was significantly associated with a history of fever during the three days preceding urine sampling (OR = 1.22, p = 0.043), socio-economic level of the population of the sites (OR = 2.74, p = 0.029), age (2–5 y = reference level; 6–9 y OR = 0.76, p = 0.002), prevalence of anti-circumsporozoite protein (CSP) antibodies (low prevalence: reference level; intermediate level OR = 2.47, p = 0.023), proportion of inhabitants who lived in another site one year before (OR = 2.53, p = 0.003), and duration to reach the nearest tarmacked road (duration less than one hour = reference level, duration equal to or more than one hour OR = 0.49, p = 0.019). CONCLUSION: Antimalarial drug pressure varied considerably from one site to another. It was significantly higher in areas with intermediate malaria transmission level and in the most accessible sites. Thus, P. falciparum strains arriving in cross-road sites or in areas with intermediate malaria transmission are exposed to higher drug pressure, which could favour the selection and the spread of drug resistance. BioMed Central 2008-07-08 /pmc/articles/PMC2494551/ /pubmed/18611279 http://dx.doi.org/10.1186/1475-2875-7-124 Text en Copyright © 2008 Gardella et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Gardella, Florence
Assi, Serge
Simon, Fabrice
Bogreau, Hervé
Eggelte, Teunis
Ba, Fatou
Foumane, Vincent
Henry, Marie-Claire
Kientega, Pélagie Traore
Basco, Léonardo
Trape, Jean-François
Lalou, Richard
Martelloni, Maryse
Desbordes, Marc
Baragatti, Meïli
Briolant, Sébastien
Almeras, Lionel
Pradines, Bruno
Fusai, Thierry
Rogier, Christophe
Antimalarial drug use in general populations of tropical Africa
title Antimalarial drug use in general populations of tropical Africa
title_full Antimalarial drug use in general populations of tropical Africa
title_fullStr Antimalarial drug use in general populations of tropical Africa
title_full_unstemmed Antimalarial drug use in general populations of tropical Africa
title_short Antimalarial drug use in general populations of tropical Africa
title_sort antimalarial drug use in general populations of tropical africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494551/
https://www.ncbi.nlm.nih.gov/pubmed/18611279
http://dx.doi.org/10.1186/1475-2875-7-124
work_keys_str_mv AT gardellaflorence antimalarialdruguseingeneralpopulationsoftropicalafrica
AT assiserge antimalarialdruguseingeneralpopulationsoftropicalafrica
AT simonfabrice antimalarialdruguseingeneralpopulationsoftropicalafrica
AT bogreauherve antimalarialdruguseingeneralpopulationsoftropicalafrica
AT eggelteteunis antimalarialdruguseingeneralpopulationsoftropicalafrica
AT bafatou antimalarialdruguseingeneralpopulationsoftropicalafrica
AT foumanevincent antimalarialdruguseingeneralpopulationsoftropicalafrica
AT henrymarieclaire antimalarialdruguseingeneralpopulationsoftropicalafrica
AT kientegapelagietraore antimalarialdruguseingeneralpopulationsoftropicalafrica
AT bascoleonardo antimalarialdruguseingeneralpopulationsoftropicalafrica
AT trapejeanfrancois antimalarialdruguseingeneralpopulationsoftropicalafrica
AT lalourichard antimalarialdruguseingeneralpopulationsoftropicalafrica
AT martellonimaryse antimalarialdruguseingeneralpopulationsoftropicalafrica
AT desbordesmarc antimalarialdruguseingeneralpopulationsoftropicalafrica
AT baragattimeili antimalarialdruguseingeneralpopulationsoftropicalafrica
AT briolantsebastien antimalarialdruguseingeneralpopulationsoftropicalafrica
AT almeraslionel antimalarialdruguseingeneralpopulationsoftropicalafrica
AT pradinesbruno antimalarialdruguseingeneralpopulationsoftropicalafrica
AT fusaithierry antimalarialdruguseingeneralpopulationsoftropicalafrica
AT rogierchristophe antimalarialdruguseingeneralpopulationsoftropicalafrica